Pathogenesis of idiopathic interstitial pulmonary fibrosis

Ultrastructural Pathology

Volumn 20, Issue 4, 1996, Pages 369-371

  Corrin, B ^a   Dewar, Ann ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

alveolar epithelium; electron microscopy; fibrosis; lung

Indexed keywords

ARTICLE; ELECTRON MICROSCOPY; FIBROSING ALVEOLITIS; HUMAN; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS EPITHELIUM; LUNG BIOPSY; PRIORITY JOURNAL;

EID: 0029814806     PISSN: 01913123     EISSN: None     Source Type: Journal    
DOI: 10.3109/01913129609016339     Document Type: Article

References (19)

1. Harrison NK, Myers AR, Corrin B, et al. Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis. 1991;144:706-713.
2. Turner-Warwick M, Doniach D. Auto-antibody studies in interstitial pulmonary fibrosis. BMJ. 1965;1:886-891.
3. Turner-Warwick M, Haslam P. Antibodies in some chronic fibrosing lung diseases. Clin Allergy. 1971;1:83-95.
4. Haslam PL, Thompson B, Mohammed I, et al. Circulating immune complexes in patients with cryptogenic fibrosing alveolitis. Clin Exp Immunol. 1979;37:381-390.
5. Turner-Warwick M, Haslam P, Weeks J. Antibodies in some chronic fibrosing lung diseases, II: immunofluorescent studies. Clin Allergy. 1971;1:209-219.
6. Schwarz MI, Dreisin RB, Pratt DS, Stanford RE. Immunofluorescent patterns in the idiopathic interstitial pneumonias. J Lab Clin Med. 1978;91:929-938.
7. Fox B, Shousha S, James KR, Miller GC. Immunohistological study of human lungs by immunoperoxidase technique. J Clin Pathol. 1982;35:144-150.
8. Gelb AF, Dreisen RB, Epstein JD, et al. Immune complexes, gallium lung scans and bronchoalveolar lavage in idiopathic interstitial pneumonitis-fibrosis: a structure-function clinical study. Chest. 1983;84:148-153.
9. Corrin B, Dewar A, Rodriguez-Roisin R, Turner-Warwick M. Fine structural changes in cryptogenic fibrosing alveolitis and asbestosis. J Pathol. 1985;147:107-119.
10. Khalil N, O'Connor RN, Unruh HW, et al. Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol. 1991;5:155-162.
11. Broekelmann TJ, Limper AH, Colby TV, Mcdonald JA. Transforming growth factor beta-1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA. 1991;88:6642-6646.
12. Corrin B, Butcher D, Mcanulty BJ, et al. Immunohistochemical localization of transforming growth factor-beta (1) in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders. Histopathology. 1994;24:145-150.
13. Nash JRG, Mclaughlin PJ, Butcher D, Corrin B. Expression of tumour necrosis factor-alpha in cryptogenic fibrosing alveolitis. Histopathology. 1993;22:343-347.
14. Giaid A, Michel RP, Stewart DJ, Sheppard M, Corrin B, Hamid Q. Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis. Lancet. 1993;341: 1550-1554.
15. Kuhn C, Boldt J, King ET, Crouch E, Vartio T. An immunohistochemical study of architectural remodelling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis. 1991;140:1693-1703.
16. Hamman L, Rich AR. Acute diffuse interstitial fibrosis of the lungs. Bull Johns Hopkins Hospital. 1944;74:177-212.
17. Katzenstein AA. Pathogenesis of 'fibrosis' in interstitial pneumonia: an electron microscopic study. Hum Pathol. 1985;16:1015-1024.
18. Burkhardt A. Pathogenesis of pulmonary fibrosis. Hum Pathol. 1986;17:971-973.
19. Burkhardt A. Alveolitis and collapse in the pathogenesis of pulmonary fibrosis. Am Rev Respir Dis. 1989;140:513-524.